Cara Therapeutics
CARA
#9716
Rank
C$33.28 M
Marketcap
$0.61
Share price
3.35%
Change (1 day)
-23.87%
Change (1 year)

Cara Therapeutics (CARA) - Cash on Hand

Cash on Hand as of September 2024 : C$60.35 Million

According to Cara Therapeutics 's latest financial reports the company has C$60.35 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cara Therapeutics - Cash on Hand chart (from 2012 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31C$0.13 B-32.27%
2022-12-31C$0.19 B-7.32%
2021-12-31C$0.21 B-7.72%
2020-12-31C$0.23 B13.95%
2019-12-31C$0.20 B-7.91%
2018-12-31C$0.21 B88.89%
2017-12-31C$0.11 B48.61%
2016-12-31C$78.31 M-47.11%
2015-12-31C$0.14 B142.29%
2014-12-31C$61.11 M364.61%
2013-12-31C$13.15 M1084.25%
2012-12-31C$1.11 M-73.35%
2011-12-31C$4.16 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
C$19.32 M-67.98%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
C$13.46 M-77.68%๐Ÿ‡บ๐Ÿ‡ธ USA
C$14.28 B 23,574.95%๐Ÿ‡บ๐Ÿ‡ธ USA
C$29.14 B 48,184.80%๐Ÿ‡บ๐Ÿ‡ธ USA
C$13.44 M-77.72%๐Ÿ‡บ๐Ÿ‡ธ USA